• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上肢痉挛缓解治疗在粗大运动功能和手动能力分类系统 IV-V 级脑瘫儿童的运动训练和矫形器辅助治疗中的应用:描述性研究。

Upper-extremity Spasticity-reducing Treatment in Adjunct to Movement Training and Orthoses in Children with Cerebral Palsy at Gross Motor Function- and Manual Ability Classification System Levels IV-V: A Descriptive Study.

机构信息

Habilitation Centre, Västerbotten County Council , Umeå, Sweden.

Department of Surgical and Perioperative Sciences, Hand and Plastic Surgery, Umeå University , Umeå, Sweden.

出版信息

Dev Neurorehabil. 2020 Aug;23(6):349-358. doi: 10.1080/17518423.2019.1655677. Epub 2019 Aug 22.

DOI:10.1080/17518423.2019.1655677
PMID:31437072
Abstract

Covering a 20-year period of work with children with severe cerebral palsy (CP) within a Swedish habilitation service, changes in passive wrist extension with fingers extended (PWE-FE) and current hand function are described and compared between children receiving systematic upper-extremity treatment with botulinum neurotoxin type A and intervention programs from before 7 years of age (Group 1, n = 7), those whom for various reasons did not undergo this treatment (Group 2, n = 10), and those not having the option to receive treatment until later during childhood/adolescence (Group 3, n = 8). Group 3 showed more critical and less normal PWE-FE values for both wrists, and poorer hand function scores, particularly compared with Group 1. Findings cautiously suggest that repeated upper-extremity spasticity-reducing treatment and movement training/orthoses from an early age may help prevent critical loss of passive range of motion of the wrist joint flexion/extension and promote hand function development in children with severe CP.

摘要

对在瑞典康复服务中为严重脑瘫 (CP) 儿童提供的 20 年工作进行了研究,描述并比较了接受 A 型肉毒毒素系统性上肢治疗和干预计划(年龄<7 岁,组 1,n = 7)的儿童、因各种原因未接受治疗的儿童(组 2,n = 10)以及直到童年/青春期后期才有机会接受治疗的儿童(组 3,n = 8)的被动手腕伸展伴手指伸展(PWE-FE)和当前手部功能的变化。两组儿童的手腕 PWE-FE 值均较差,手部功能评分也较低,尤其是与组 1 相比。研究结果谨慎地表明,反复进行上肢痉挛减轻治疗和早期的运动训练/矫形器可能有助于预防严重 CP 儿童腕关节屈伸活动度的严重丧失,并促进手部功能的发展。

相似文献

1
Upper-extremity Spasticity-reducing Treatment in Adjunct to Movement Training and Orthoses in Children with Cerebral Palsy at Gross Motor Function- and Manual Ability Classification System Levels IV-V: A Descriptive Study.上肢痉挛缓解治疗在粗大运动功能和手动能力分类系统 IV-V 级脑瘫儿童的运动训练和矫形器辅助治疗中的应用:描述性研究。
Dev Neurorehabil. 2020 Aug;23(6):349-358. doi: 10.1080/17518423.2019.1655677. Epub 2019 Aug 22.
2
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.A型肉毒毒素作为治疗痉挛型脑瘫患儿上肢的辅助治疗手段。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD003469. doi: 10.1002/14651858.CD003469.pub3.
3
Effects of Botulinum Toxin A Injection on Ambulation Capacity in Patients with Cerebral Palsy.A型肉毒毒素注射对脑瘫患者步行能力的影响。
Dev Neurorehabil. 2019 May;22(4):288-291. doi: 10.1080/17518423.2018.1502832. Epub 2018 Aug 10.
4
Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.将力量训练与肉毒毒素干预相结合治疗脑瘫儿童:对肌肉形态和力量的影响。
Disabil Rehabil. 2013 Apr;35(7):596-605. doi: 10.3109/09638288.2012.711898. Epub 2012 Aug 28.
5
Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.A型肉毒毒素作为辅助治疗手段用于痉挛型脑瘫患儿上肢的治疗。
Cochrane Database Syst Rev. 2004(3):CD003469. doi: 10.1002/14651858.CD003469.pub2.
6
A randomized trial of upper limb botulimun toxin versus placebo injection, combined with physiotherapy, in children with hemiplegia.一项针对偏瘫儿童的随机试验:上肢注射肉毒杆菌毒素与安慰剂,并结合物理治疗。
Res Dev Disabil. 2014 Oct;35(10):2505-13. doi: 10.1016/j.ridd.2014.06.001. Epub 2014 Jul 2.
7
Effects of botulinum toxin A and/or bimanual task-oriented therapy on upper extremity impairments in unilateral Cerebral Palsy: an explorative study.A型肉毒毒素和/或双手任务导向疗法对单侧脑瘫上肢功能障碍的影响:一项探索性研究。
Eur J Paediatr Neurol. 2015 May;19(3):337-48. doi: 10.1016/j.ejpn.2015.01.004. Epub 2015 Jan 26.
8
Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.A型肉毒杆菌毒素对上肢痉挛型脑瘫的影响。
Am J Phys Med Rehabil. 2003 Apr;82(4):284-9. doi: 10.1097/01.PHM.0000056989.67763.07.
9
Minimising impairment: Protocol for a multicentre randomised controlled trial of upper limb orthoses for children with cerebral palsy.减少损伤:一项针对脑瘫儿童上肢矫形器的多中心随机对照试验方案
BMC Pediatr. 2016 May 27;16:70. doi: 10.1186/s12887-016-0608-8.
10
Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications.A型肉毒毒素治疗痉挛型脑瘫和获得性脑损伤患儿上肢的临床意义
Eur J Neurol. 2001 Nov;8 Suppl 5:136-44. doi: 10.1046/j.1468-1331.2001.00046.x.

引用本文的文献

1
The state of the art in therapeutic administration of botulinum toxin in children with cerebral palsy: an integrative review.治疗脑瘫儿童肉毒杆菌毒素的最新进展:综合评价。
Rev Paul Pediatr. 2024 Mar 25;42:e2023093. doi: 10.1590/1984-0462/2024/42/2023093. eCollection 2024.